Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

5 Injured in Crash at Highway 118 and Price Road


3 Vehicles Involved in Somis Accident

Any Type of Accident 7

Somis, CA (October 6, 2019) – Five people were injured in a multi-vehicle crash in Somis. The accident occurred on the afternoon of October 6 at Highway 118 and Price Road.

A pickup truck and two passenger cars were involved on Highway 118 and Price Road. One person was trapped and emergency crews had to use the Jaws of Life to free the victim. Five people were injured in the crash. All suffered minor injuries. 

#Somis

#93066


October 10, 2019

Dylan Duthridge Injured in Crash at Norris Road and Arvin Street

Teen Hit By Car in Oildale Pedestrian Accident Oildale, CA (October 9, 2019) ...


April 15, 2020

Pedestrian Killed in Crash on 55 Freeway Near McFadden Avenue

Man Hit by Car in Fatal Tustin Accident...


November 27, 2019

2 Killed in Crash at 66th Avenue and Grant Street

ATV, 2 Other Vehicles Involved in Fatal Mecca Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.